The evidence supporting this hypothesis is that a subset of B‐CLL cells with unresponsiveness to sIg ligation display constitutively activated extracellular signal‐regulated kinase ERK1/2 in the absence of Akt activation and the presence of increased NFAT transactivation 47. The gene discussed is MAPK3; the disease is B-cell chronic lymphocytic leukemia.